24. An Introduction to Anticancer Drugs
Ian Mullaney
School of Pharmacy, Faculty of Health Sciences, Murdoch University, Murdoch, WA6150, Australia.
Phone +61 8 93601236 Fax +61 8 93601240 Email i.mullaney@murdoch.edu.au
Reviewed by Elizabeth Davis, Monash University
Key words: anti-cancer drugs, alkylating agents, cyclophosphamide, ifosfamide, cytotoxic antibodies, daunorubicin, doxorubicin, antimetabolites, methotrexate, 6-mercaptopuring, 6-thioguanine, 5-fluorourcil, capecitabine, cytarabine, gemcitabine, microtubule inhibitors, vincristine, vinblastine, paclitaxel, docetaxol, monoclonal antibodies, rituximab, trastuzumab, beviacizumab, alemtuzumab, panituxumab, ibritumomab tiuxetan, steroid hormones and their antagonists, anastrozole, exemestane, letrozole, tamoxifen, leuprolide, goserelin, flutamide, bicalutamide, prednisolone, cisplatin, carboplatin, oxaliplatin
Contents
24. An introduction to anticancer drugs
24.1 Introduction
24.2 The rationale behind anticancer drug therapy
24.3 Drugs used in cancer
24.3.1 Alkylating agents
24.3.2 Cytotoxic antibiotics
24.3.3 Antimetabolites
24.3.4 Microtubule inhibitors
24.3.5 Monoclonal antibodies
24.3.6 Steroid hormones and their antagonists
24.3.7 Other treatments